Picture of Bb Biotech logo

BION Bb Biotech News Story

0.000.00%
ch flag iconLast trade - 00:00
FinancialsBalancedMid CapSuper Stock

Swiss agree deal with Pfizer for 14 million more COVID-19 vaccine doses

ZURICH, Aug 25 (Reuters) - Switzerland has signed an
agreement with Pfizer  PFE.N  to supply 14 million more doses of
its COVID-19 vaccine to cover 2022 and 2023, Health Minister
Alain Berset said on Wednesday.
    "The Swiss government has completed a further contract with
Pfizer, which will supply 7 million vaccine doses (in both) 2022
and 2023," Berset told a press conference in Bern.
    The contract includes an option for an additional 7 million
doses to be supplied to Switzerland each year, Berset said.
"With this, the Swiss population will have access to enough
vaccine in the coming two years," Berset said. 
    

 (Reporting by John Revill; editing by Brenna Hughes Neghaiwi)
 ((John.Revill@thomsonreuters.com; +41 58306 7022; Reuters
Messaging: john.revill.thomsonreuters.com@reuters.net))

Recent news on Bb Biotech

See all news